scholarly journals Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events

Oncotarget ◽  
2018 ◽  
Vol 9 (22) ◽  
pp. 16263-16270 ◽  
Author(s):  
Tatsuo Kanda ◽  
Shin Yasui ◽  
Masato Nakamura ◽  
Shingo Nakamoto ◽  
Koji Takahashi ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Adverse Events ◽  
Prior Treatment ◽  
Virus Genotype ◽  
Ns5a Inhibitor ◽  
Genotype 1B

Efficacy and safety of elbasvir plus grazoprevir combination therapy in Japanese patients infected with hepatitis C virus genotype 1b

2018 ◽  
Vol 49 (3) ◽  
pp. 256-263 ◽  
Author(s):  
Yasue Takeuchi ◽  
Norio Akuta ◽  
Hitomi Sezaki ◽  
Fumitaka Suzuki ◽  
Shunichiro Fujiyama ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Combination Therapy ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
Virus Genotype ◽  
Genotype 1B

Ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin for chronic hepatitis C virus genotype 1b-infected cirrhotics (TURQUOISE-IV)

2018 ◽  
Vol 30 (9) ◽  
pp. 1073-1076 ◽  
Author(s):  
Vasily Isakov ◽  
Dzmitry Paduta ◽  
Rolando M. Viani ◽  
Jeffrey V. Enejosa ◽  
Viktor Pasechnikov ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Virus Genotype ◽  
Genotype 1B ◽  
Chronic Hepatitis C Virus
Sign in / Sign up

Export Citation Format

Share Document